Group One Trading’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-32,720
Closed -$4.58K 7708
2024
Q1
$4.58K Sell
32,720
-32,177
-50% -$6.34K ﹤0.01% 6223
2023
Q4
$9.44K Hold
64,897
﹤0.01% 6245
2023
Q3
$11.4K Sell
64,897
-9,790
-13% -$12.2K ﹤0.01% 6271
2023
Q2
$233K Buy
+74,687
New +$222K ﹤0.01% 3775
2023
Q1
Sell
-3,413
Closed -$7.04K 8135
2022
Q4
$5.08K Buy
3,413
+2,560
+300% +$4.15K ﹤0.01% 6345
2022
Q3
$1K Buy
+853
New +$1.21K ﹤0.01% 7404
2022
Q2
Sell
-34,353
Closed -$58.8K 8720
2022
Q1
$82K Sell
34,353
-34,292
-50% -$89.3K ﹤0.01% 5690
2021
Q4
$315K Buy
+68,645
New +$227K ﹤0.01% 4615

Other funds holding GRTX

Group One Trading's GRTX Position: Q2 2024 in Review

Group One Trading sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 32,720 shares — an estimated $4.58K sold.

Group One Trading first reported a position in GRTX in Q4 2021 and held it in 8 quarters. The position peaked at $315K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Group One Trading reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 32,720 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.58K.
  • Group One Trading first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Group One Trading's Galera Therapeutics, Inc. Common Stock position peaked at $315K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.